Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Grunin

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
BMC Ophthalmology|April 17, 2015
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcomeGala Beykin, Michelle Grunin, Edward Averbukh, et al.
Molecular Vision|October 8, 2019
Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degenerationSarah Elbaz-Hayoun, Batya Rinsky, Shira Hagbi-Levi, et al.
European Journal of Ophthalmology|May 22, 2014
Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophyLiran Tiosano, Tareq Jaouni, Edward Averbukh, et al.
The British Journal of Ophthalmology|January 24, 2016
Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophyLiran Tiosano, Michelle Grunin, Shira Hagbi-Levi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 16, 2012
Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphismTareq Jaouni, Edward Averbukh, Tal Burstyn-Cohen, et al.
European Journal of Ophthalmology|May 5, 2020
Socioeconomic status and visual outcome in patients with neovascular age-related macular degenerationNadav Levinger, Gala Beykin, Michelle Grunin, et al.
Plos One|March 4, 2014
Degeneration modulates retinal response to transient exogenous oxidative injuryMichal Lederman, Shira Hagbi-Levi, Michelle Grunin, et al.
Journal of Immunology Research|August 31, 2019
Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte RecruitmentShira Hagbi-Levi, Michal Abraham, Liran Tiosano, et al.
Neurobiology of Aging|January 1, 2017
Proangiogenic characteristics of activated macrophages from patients with age-related macular degenerationShira Hagbi-Levi, Michelle Grunin, Tareq Jaouni, et al.
Molecular Vision|December 20, 2021
Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degenerationShira Hagbi-Levi, Liran Tiosano, Batya Rinsky, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
BMC Ophthalmology|April 17, 2015
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcomeGala Beykin, Michelle Grunin, Edward Averbukh, et al.
Molecular Vision|October 8, 2019
Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degenerationSarah Elbaz-Hayoun, Batya Rinsky, Shira Hagbi-Levi, et al.
European Journal of Ophthalmology|May 22, 2014
Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophyLiran Tiosano, Tareq Jaouni, Edward Averbukh, et al.
The British Journal of Ophthalmology|January 24, 2016
Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophyLiran Tiosano, Michelle Grunin, Shira Hagbi-Levi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 16, 2012
Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphismTareq Jaouni, Edward Averbukh, Tal Burstyn-Cohen, et al.
European Journal of Ophthalmology|May 5, 2020
Socioeconomic status and visual outcome in patients with neovascular age-related macular degenerationNadav Levinger, Gala Beykin, Michelle Grunin, et al.
Plos One|March 4, 2014
Degeneration modulates retinal response to transient exogenous oxidative injuryMichal Lederman, Shira Hagbi-Levi, Michelle Grunin, et al.
Journal of Immunology Research|August 31, 2019
Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte RecruitmentShira Hagbi-Levi, Michal Abraham, Liran Tiosano, et al.
Neurobiology of Aging|January 1, 2017
Proangiogenic characteristics of activated macrophages from patients with age-related macular degenerationShira Hagbi-Levi, Michelle Grunin, Tareq Jaouni, et al.
Molecular Vision|December 20, 2021
Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degenerationShira Hagbi-Levi, Liran Tiosano, Batya Rinsky, et al.
Pageof 5